Taro Pharmaceutical Industries Ltd. TARO
$ 42.97
0.0%
Annual report 2022
added 07-25-2022
Taro Pharmaceutical Industries Ltd. Financial Ratios 2011-2024 | TARO
Annual Financial Ratios Taro Pharmaceutical Industries Ltd.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
23.3 | -4.7 | 11.2 | 14.9 | 16.9 | 9.2 | 9.7 | 10.9 | 12.1 | 8.9 | 36.3 | 6.7 |
P/S |
2.4 | 3.3 | 4.2 | 6.3 | 5.4 | 4.8 | 5.5 | 6.1 | 5.7 | 3.5 | 11.8 | 2.4 |
EPS |
1.6 | -10.1 | 6.3 | 7.2 | 5.3 | 11.1 | 12.6 | 11.3 | 8.1 | 6.0 | - | 4.1 |
EV (Enterprise Value) |
1.57 B | 1.94 B | 2.45 B | 3.85 B | 3.23 B | 3.84 B | 4.91 B | 5.1 B | 4.4 B | 2.34 B | 1.72 B | 1.31 B |
EBITDA per Share |
2.37 | -10.2 | 6.97 | 8.07 | 7.96 | 12.8 | 14.7 | 12.7 | 10.1 | 7.75 | 1.59 | 5.02 |
EV/EBITDA |
-4.7 | 8.0 | 11.5 | 9.4 | 6.8 | 7.4 | 8.8 | 9.3 | 6.2 | 21.3 | 5.0 | |
PEG |
-0.28 | 0.08 | -1.19 | 0.4 | -0.32 | -0.74 | 0.83 | 0.28 | 0.33 | 0.02 | -0.49 | 0.04 |
P/B |
0.8 | 1.1 | 1.3 | 2.2 | 1.6 | 2.0 | 2.7 | 3.7 | 4.3 | 2.7 | 2.8 | 2.2 |
P/CF |
-8.5 | 40.1 | 10.1 | 14.3 | 12.2 | 10.5 | 13.9 | 13.6 | 13.1 | 9.9 | 22.4 | 7.0 |
ROE % |
3.40 | -22.70 | 11.58 | 14.79 | 9.58 | 22.07 | 28.01 | 34.30 | 35.49 | 30.03 | 7.64 | 32.21 |
ROA % |
2.68 | -16.06 | 10.43 | 13.20 | 8.68 | 19.93 | 24.72 | 27.87 | 28.06 | 24.06 | 5.52 | 22.96 |
ROCE % |
3.64 | -23.80 | 11.60 | 15.44 | 13.66 | 24.76 | 31.63 | 36.96 | 41.73 | 35.95 | 10.07 | 33.81 |
Current Ratio |
4.7 | 3.4 | 9.9 | 6.8 | 8.8 | 9.5 | 7.6 | 4.9 | 4.2 | 4.7 | 3.3 | 3.1 |
DSO |
149.7 | 149.2 | 133.9 | 151.6 | 178.2 | 136.7 | 110.3 | 112.3 | 77.7 | 67.1 | 292.1 | 90.5 |
DIO |
265.9 | 241.1 | 224.3 | 241.1 | 266.0 | 247.7 | 297.9 | 235.6 | 239.4 | 227.2 | 869.7 | 222.6 |
DPO |
2.1 | 4.5 | 4.5 | 109.1 | 114.7 | 93.6 | 143.9 | 122.8 | 108.5 | 96.6 | 447.5 | 115.2 |
Operating Cycle |
415.6 | 390.3 | 358.2 | 392.7 | 444.2 | 384.4 | 408.2 | 347.8 | 317.1 | 294.3 | 1161.7 | 313.1 |
Cash Conversion Cycle |
413.4 | 385.8 | 353.8 | 283.6 | 329.5 | 290.8 | 264.3 | 225.1 | 208.6 | 197.7 | 714.2 | 197.9 |
All numbers in USD currency
Quarterly Financial Ratios Taro Pharmaceutical Industries Ltd.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06 | - | - | - | 0.58 |
EBITDA per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.59 | - | - | - | 0.86 |
ROE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.63 | 15.27 | 15.27 | 7.63 | 7.63 | - | - | - | - |
ROA % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.52 | 11.03 | 11.03 | 5.52 | 5.52 | - | - | - | - |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.13 | 20.26 | 20.26 | 10.13 | 10.13 | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | 3.4 | - | - | - | 10.1 | - | - | - | 9.5 | - | - | - | 10.9 | - | - | - | 10.6 | - | - | - | 8.7 | - | - | - | 5.4 | - | - | - | 4.9 | - | - | - | 5.1 | - | - | - | 3.7 | 3.5 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 72.9 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 215.4 | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.6 | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 288.3 | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 264.7 | - | - | - | - |
All numbers in USD currency